Works matching IS 25155091 AND DT 2022 AND VI 6 AND IP 4


Results: 17
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial.

    Published in:
    JNCI Cancer Spectrum, 2022, v. 6, n. 4, p. 1, doi. 10.1093/jncics/pkac043
    By:
    • James, Nicholas D;
    • Ingleby, Fiona C;
    • Clarke, Noel W;
    • Amos, Claire L;
    • Attard, Gerhardt;
    • Brawley, Christopher D;
    • Chowdhury, Simon;
    • Cross, William;
    • Dearnaley, David P;
    • Gilbert, Duncan C;
    • Gillessen, Silke;
    • Jones, Robert J;
    • Langley, Ruth E;
    • Macnair, Archie;
    • Malik, Zafar I;
    • Mason, Malcolm D;
    • Matheson, David J;
    • Millman, Robin;
    • Parker, Chris C;
    • Rush, Hannah L
    Publication type:
    Article
    15
    16
    17